OR WAIT null SECS
The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.
June 30, 2025
Article
Discover groundbreaking FDA approvals in 2025 that redefine treatment standards, enhance patient care, and address critical public health needs.
An audio recap of the top 5 stories in healthcare news from the week of 06/16-06/22
The CRL cited deficiencies previously identified at a third-party manufacturing vendor unrelated to OLC, and the Company plans to request a Type A meeting.
June 27, 2025
We spotlight 7 impactful regulatory decisions scheduled to occur during the second half of 2025.
June 25, 2025
Video
From new data for potential IgAN treatments to the use of combination initiation therapy for type 2 diabetes and CKD, here are 5 key updates from the annual meeting.
June 24, 2025
With the approval, children ≥ 5 years of age with active lupus nephritis will have a first-of-its-kind treatment option for at-home administration.
June 22, 2025
A global study reveals that universal access to semaglutide could save 28 million lives and significantly reduce obesity and diabetes worldwide.
June 20, 2025
From barriers to implementing evidence-based care to innovations in combination therapy, here are 5 key updates from the annual meeting.
Investigators also noted the risk of Hb overshoot in patients switching from ESA to roxadustat, emphasizing the importance of monitoring Hb levels before and after treatment.
June 10, 2025
A recap of 3 Kidney Compass podcast episodes recorded at ERA 2025, including summaries and preview clips.